跳至主要内容
临床试验/NCT02442505
NCT02442505已完成不适用

Validation of the Modified Microlife Blood Pressure Monitor in Patients With Paroxysmal Atrial Fibrillation

University of Birmingham1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2013年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
48
试验地点
1
主要终点
Percentage of patients who are identified as not having atrial fibrillation by both the pacemaker and the Microlife device (%)

研究概览

简要总结

This study will use an automated blood pressure monitor (Microlife WatchBP03) with an inbuilt algorithm to detect atrial fibrillation (an irregular heart rhythm) in patients with an implanted pacemaker who have previously documented paroxysmal (intermittent) atrial fibrillation. This study will compare the Microlife device detected atrial fibrillation episodes to the pacemaker detected atrial fibrillation episodes.

详细描述

The modified Microlife blood pressure monitor is able to detect atrial fibrillation (AF) with high sensitivity (95%) and specificity (86%) and has a positive predictive value of 68% and negative predictive value of 98% for single readings. In addition, the modified device was also able to accurately classify the majority of the anomalous non-AF rhythms, although the specificity was highly variable, dependent upon the rhythm. However sinus rhythm was detected with a specificity of 97%. However, we do not currently know if the device would demonstrate a similar sensitivity in detecting AF in patients with paroxysmal AF.

Therefore, the present study will assess the sensitivity and specificity of the automated oscillometric device using a new AF algorithm among pacemaker patients with fast AF and atrial high-rate episodes and evaluate the effect of the specific rhythm abnormalities on the specificity for AF.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with an implanted pacemaker for sick sinus syndrome with previously documented AF with atrial high-rate episodes

排除标准

  • Any patient who's pacemaker has had previously documented atrial sensing or pacing problem issues
  • Patients with permanent AF

结局指标

主要结局

Percentage of patients who are identified as not having atrial fibrillation by both the pacemaker and the Microlife device (%)

时间窗: 24 hours

True negative rate (specificity)

Percentage of patients who are identified as having atrial fibrillation by both the pacemaker and the Microlife device (%)

时间窗: 24 hours

True positive rate (sensitivity)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验